Particle Sciences Further Expands Combination Product Development Capabilities

BETHLEHEM, Pa., June 16 /PRNewswire/ -- Particle Sciences Inc., a leading
service provider for the development of thermoplastic based Combination
Products (drug-eluting devices), has further expanded their development and
pilot production capabilities with the addition of a Leistritz ZSE-18mm twin
screw compounding extruder. This expands a compounding, extrusion,
pelletization and injection molding line that is suitable for the preparation
of high quality Combination Products to support clients' development programs.
"With the addition of the Leistritz compounding extruder to our Class 10,000
clean room, Particles Sciences offers development services for thermoplastic
Combination Products. We can support such development efforts from concept to
clinic," says Dr. Andrew Loxley, Director of New Technologies. Dr. Robert W.
Lee, (VP of Pharmaceutical Development) adds, "We are very pleased with the
interest we have generated so far. We are now actively working on three
Combination Products from different clients, all based on small molecule
release from thermoplastics."

Particle Sciences is an integrated provider of drug development services.
Particle Sciences focuses on emulsions, gels, particulates and drug/device
combination products with additional specialized capabilities in topical and
mucosal drug delivery. Through a full range of formulation, analytic, and
manufacturing services, Particle Sciences provides pharmaceutical companies
with a complete and seamless development solution that minimizes the time and
risk between discovery and the clinic. The company was founded in 1991 and is
headquartered in Bethlehem, Pennsylvania. Visit www.particlesciences.com,
email info@particlesciences.com or contact us at (610) 861-4701 for
information.

Contact:
Maureen Cochran
mcochran@particlesciences.com
+1-610-861-4701

SOURCE Particle Sciences, Inc.

Maureen Cochran of Particle Sciences Inc., +1-610-861-4701,
mcochran@particlesciences.com